RBR-103p86cv进行中(未招募)4 期
The impact of using MPFF 1000mg/day in improving symptoms, complications and quality of life in patients with CVD under sclerotherapy: a prospective randomized study
MEDCOG Treinamentos, Locações e Organizações de Eventos em Angiologia e Cirurgia Vascular Ltda0 个研究点开始时间: 2024年2月26日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18Y 至 60Y(—)
入选标准
- •Pacients aged between 18 and 60 years; of both genders; with Chronic Venous Disease – CVD; able to understand and sign (or their representative) the Informed Consent Form ICF
排除标准
- •Patients with insufficient perforating veins or saphenous veins (magna and/or parva) detected on ultrasound examination; pregnancy; puerperium; peripheral arterial disease; known thrombophilia; previous history of thrombosis; use of anticoagulants; allergy to polidocanol; active infectio; history of asthma and migraine
研究者
相似试验
尚未招募
不适用
Effect of PRF as a complementary therapy in the treatment of periodontal diseasePeriodontal PocketH02.163.876.623RBR-52h647mFaculdade de Odontologia da Universidade Federal de Uberlândia
尚未招募
不适用
Development of MFT treatment support application as a medical device programMalocclusionJPRN-UMIN000046941Tokyo Medical and Dental University40
进行中(未招募)
不适用
Can patients with fibromyalgia be improved by subcutaneous injections of sterile water in tenderpoints? A randomised, controlled, tripple masked clinical trialFibromyalgiaEUCTR2005-000654-67-SEppsala University/Uppsala County Council60
已完成
2 期
Effects of Pulsed Magnetic Pads on Rheumatoid Arthritis Symptoms in Postmenopausal WomenRheumatoid ArthritisMenopauseNCT00110565National Center for Complementary and Integrative Health (NCCIH)87
招募中
不适用
Value of FGFR alterations on treatment outcomes in bladder cancer: a multicenter collaboration projectC67C64C56C66C68Malignant neoplasm of bladderMalignant neoplasm of kidney, except renal pelvisMalignant neoplasm of ovaryMalignant neoplasm of ureterMalignant neoplasm of other and unspecified urinary organsDRKS00016925Stratifyer Molecular Pathology120
